BioSpace News Archive

Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today provided business updates and reported financial results for the fiscal quarter and full year ended December 31, 2023.

Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced its financial results for the full year ended December 31, 2023, and provided an update on recent corporate highlights.

Congruence Therapeutics, a computationally-driven biotechnology company building a unique pipeline of transformative small molecule correctors rationally designed to rescue aberrant protein function, announced that it will participate in the following investor conferences.

STRATA Skin Sciences, Inc. announced financial results for the fourth quarter and full-year ended December 31, 2023.

REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in Cantor Fitzgerald’s Virtual DMD and Other Dystrophy Days on Wednesday, April 3, 2024.

Insmed Incorporated (Nasdaq: INSM) today announced that it will present nine abstracts from across its respiratory portfolio at the American Thoracic Society (ATS) 2024 International Conference, taking place May 17-22, 2024, in San Diego.

Varex Imaging Corporation announced it has entered into a senior secured revolving credit agreement for an initial aggregate principal amount of up to $155 million.

Revance Therapeutics, Inc. announced new hire grants totaling an aggregate of 222,452 inducement restricted stock units to 29 employees.

Inhibikase Therapeutics, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023 and highlighted recent developments.

Dermata Therapeutics, Inc. (Nasdaq:DRMA; DRMAW) (“Dermata” or the “Company”), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions, today announced it will be featured as a presenting company at the Emerging Growth Conference on April 3, 2024.